Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,686
Closed -$641K 637
2025
Q1
$641K Buy
+4,686
New +$670K ﹤0.01% 573
2023
Q4
Sell
-11,137
Closed -$2.86M 719
2023
Q3
$2.86M Sell
11,137
-939
-8% -$251K 0.02% 406
2023
Q2
$3.44M Sell
12,076
-651
-5% -$194K 0.03% 386
2023
Q1
$3.54M Buy
12,727
+11,107
+686% +$3.07M 0.02% 327
2022
Q4
$449K Buy
+1,620
New +$458K ﹤0.01% 696

Other funds holding BIIB

AGF Management's BIIB Position: Q2 2025 in Review

AGF Management sold out of Biogen (BIIB) in Q2 2025, closing a stake of 4,686 shares — an estimated $641K sold.

AGF Management first reported a position in BIIB in Q4 2022 and held it in 5 quarters. The position peaked at $3.54M in Q1 2023. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.

  • AGF Management reported no remaining Biogen position as of Q2 2025 after selling out during the quarter.
  • AGF Management sold 4,686 Biogen shares in Q2 2025, an estimated $641K.
  • AGF Management first reported a position in Biogen in Q4 2022 and held it in 5 quarters.
  • AGF Management's Biogen position peaked at $3.54M in Q1 2023.
  • 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.

Based on AGF Management's 13F filing for Q2 2025, filed 6 Aug 2025.